Neurofibromatosis Therapeutic Acceleration Program
@ntapresearch
Followers
174
Following
109
Media
49
Statuses
109
Accelerating the development of effective therapeutics for plexiform and cutaneous neurofibromas
Baltimore, Maryland
Joined May 2023
NTAP is proud to support @VasuLabUCSF and team's research published in @JCI_insight "Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma" #EndNF #NFResearch
NF1 is frequently mutated in #glioblastoma, yet therapies targeting this alteration often fall short. @VasuLabUCSF & team @UCSF now show NF1 mutant glioblastomas exhibit prognostic signatures with distinct sensitivity to MEK inhibition: https://t.co/FRfozC2Arh
0
0
2
A powerful tribute to Dr. Verena Staedtke’s vision. Huge congratulations to Dr. Bai, @jblakel3, and the NTAP/JH/KKI teams for this exciting step forward. Grateful for the progress — and hopeful for what’s ahead. #EndNF #NFResearch
Honoring Verena Staedtke’s vision, @JohnsHopkins researchers, led by Renyuan Bai w/ support from Jaishri Blakeley at @ntapresearch, are advancing gene therapy for NF1. An AAV vector delivering neurofibromin shows promise + hope for patients. https://t.co/X1MEWqhjwF
0
2
3
A major milestone for the NF1 community. Congratulations to all involved. Here's to continued momentum in NF research and drug development! #EndNF #NFResearch
#FDA approves a treatment for adults with neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas. https://t.co/KGjyhJr3n0
0
2
4
NF1 Researcher? NTAP launched a Scholars program to support early-career PhD-level scientists. LOIs are due on October 20th. Apply today!
0
0
1
1 day way! Join us tomorrow at 10AM for the Francis Collins Scholars Information session.
Are you an early-career clinician-scientist? Ready to make an impact on NF1 research? Join us for an information session on the Francis Collins Scholars Program. Wednesday, October 1, 2025 @ 10 AM EST 🔗 Register here: https://t.co/4fxFBjIFTD
#Research #EndNF #NF1
0
0
1
Are you an early-career clinician-scientist? Ready to make an impact on NF1 research? Join us for an information session on the Francis Collins Scholars Program. Wednesday, October 1, 2025 @ 10 AM EST 🔗 Register here: https://t.co/4fxFBjIFTD
#Research #EndNF #NF1
0
3
4
Fueling the next wave of NF research: Nearly $1.5M in Young Investigator Awards will drive cutting-edge science, smarter care & real solutions for NF1, NF2-SWN & SWN. Meet the early-career scientists shaping NF’s future: https://t.co/BSAlaSPfS5
0
1
6
App open thru 9/8! Junior faculty, fellows, postdocs & PhD students in #NFresearch—apply now for the NFYIF: a career-catalyzing event for mentorship, productivity & community https://t.co/9Zr406jCn6
#EndNF #Neurofibromatosis #YoungInvestigators #PostdocLife #PhDlife #ceconcepts
0
1
1
Incredible time for the Francis Collins Scholars community! Our 7 summer interns shared powerful NF1 research on MPNST, optic gliomas, GI symptoms & neuropsychiatric profiles. Huge thanks to mentors & supporters! #FrancisCollinsScholars #NFResearch
0
1
5
🚨Updated Criteria! NTAP @HopkinsMedicine is funding early-career PhD (or equivalent) scientists focused on NF1 🧬 Learn more: NF1 Laboratory Scholars Program—mentorship, salary + project support! 🔗 https://t.co/bcctPpiwJ7 · LOI due: Oct 20, 2025 #EndNF
n-tap.org
NTAP launched new funding for early-career PhD-level NF1 scientists, addressing a critical training gap and accelerating discovery in research.
0
1
2
🚨 Just 20 days left! 🚨 Apply by Aug 13 for up to $50K from the DHART SPORE DRP & CEP Awards to support NF1 & Rasopathy research. Open to clinical, population & basic science investigators. 🔗 https://t.co/3X8nGUG1S0
#NF1 #ResearchFunding #DHARTSPORE
0
2
4
🚨 Double the funding, double the chance! Apply now for the DHART SPORE Developmental Research Program (DRP) & Career Enhancement Program (CEP) Awards. Don’t miss out! 🔗 Apply here: https://t.co/hWxt8PzZzh 🗓️ Deadline: August 13, 2025
0
0
0
The cancer center’s D. Wade Clapp, MD, and colleagues have published their latest findings in the Journal of Neuro-Oncology. Learn more: https://t.co/SLa386gtkO.
#ResearchCuresCancer #NCIcomprehensive @JNeurooncol
0
3
5
We're excited to have @BettegowdaMDPHD from @HopkinsNsurg join us this week for our #Neurosurgery Grand Rounds!
1
9
77
Congrats! Excited to see the next generation of scientists driving discovery for the NF1 community. Make this summer count! 🔬🧬 #NF1 #Research #FutureScientists #SummerInterns #TeamScience
Please join us in welcoming our amazing summer interns to BRIDGE Lab! We’re thrilled to have Tali, Catalina, and Annetta join the team. Each of them brings curiosity, enthusiasm, and fresh perspective to our work, and we’re excited to learn and grow together this summer.
0
1
1
Pipeline of experts advances discovery in neurofibromatosis https://t.co/VVEGLrcvM0 via @HubJHU Accepting applications now for the 2026 Francis Collins Scholars Program. #EndNF #NFResearch
hub.jhu.edu
JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars Program, an initiative that has led to research and treatment breakthroughs...
0
1
3
🧬 Help Advance Genomic Interpretation—Join a CAGI7 Challenge! Sage Bionetworks is excited to support the recently launched CAGI7 (Critical Assessment of Genome Interpretation) challenges—open to researchers, data scientists, and students who want to help predict the functional
0
2
3
Grateful for Dr. Karen Horton’s inspiring leadership at @Hopkins_Rad 🙌 and the Reames family for their support —she’s shaping the next generation of radiology leaders. #MedicalEducation #Radiology #FutureOfMedicine #ThankYou
Karen Horton, MD, leads @Hopkins_Rad with a vision for innovation in care, education, and research. With support from the Reames family, she’s ensuring trainees are prepared for the radiology of the future. #FacultyFriday Read more: https://t.co/U2T223ChtL
0
1
3
Are you an early-career clinician scientist passionate about transforming care for people with NF1? The Francis Collins Scholars Program is a prestigious, fully funded opportunity - now accepting applications. Learn more at https://t.co/JzDqVcYekF
0
3
3